Dr. Pankit Vachhani
Claim this profileUniversity of Alabama at Birmingham
Studies Leukemia
Studies Acute Myeloid Leukemia
15 reported clinical trials
23 drugs studied
Area of expertise
1Leukemia
FLT3 positive
CBF positive
Philadelphia chromosome positive
2Acute Myeloid Leukemia
FLT3 positive
CBF positive
Affiliated Hospitals
Clinical Trials Pankit Vachhani is currently running
BLU-263
for Systemic Mastocytosis
This trial tests BLU-263 combined with the best possible care for patients with specific conditions whose symptoms are not well-controlled. The medication aims to reduce symptoms by blocking overactive cells.
Recruiting0 awards Phase 2 & 312 criteria
Pembrolizumab + Chemotherapy
for Acute Myeloid Leukemia
This phase II trial studies how well cytarabine and idarubicin or daunorubicin with or without pembrolizumab work in treating patients with newly-diagnosed acute myeloid leukemia. Chemotherapy drugs, such as cytarabine, idarubicin, and daunorubicin, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving induction chemotherapy with pembrolizumab may work better than induction chemotherapy alone in treating patients with acute myeloid leukemia.
Recruiting1 award Phase 210 criteria
More about Pankit Vachhani
Clinical Trial Related2 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Pankit Vachhani has experience with
- Placebo
- MT-401
- NTX-301
- ZN-d5
- ZN-c3
- TAS1553
Breakdown of trials Pankit Vachhani has run
Leukemia
Acute Myeloid Leukemia
Myeloid Leukemia
Myelodysplastic Syndrome
Chronic Myelomonocytic Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Pankit Vachhani specialize in?
Pankit Vachhani focuses on Leukemia and Acute Myeloid Leukemia. In particular, much of their work with Leukemia has involved FLT3 positive patients, or patients who are CBF positive.
Is Pankit Vachhani currently recruiting for clinical trials?
Yes, Pankit Vachhani is currently recruiting for 10 clinical trials in Birmingham Alabama. If you're interested in participating, you should apply.
Are there any treatments that Pankit Vachhani has studied deeply?
Yes, Pankit Vachhani has studied treatments such as Placebo, MT-401, NTX-301.
What is the best way to schedule an appointment with Pankit Vachhani?
Apply for one of the trials that Pankit Vachhani is conducting.
What is the office address of Pankit Vachhani?
The office of Pankit Vachhani is located at: University of Alabama at Birmingham, Birmingham, Alabama 35249 United States. This is the address for their practice at the University of Alabama at Birmingham.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.